ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
183 | (±¹¿Ü)SCIE | Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites |
182 | (±¹¿Ü)SCI | A multicenter phase II study of sorafenib in combination with erlotinibin patients with advanced non-small cell lung cancer (KCSG-0806) |
181 | (±¹¿Ü)SCI | Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabineresistant pancreatic cancer cells |
180 | (±¹¿Ü)±âŸ | Targeting the indoleamine 2,3-dioxygenase pathway in cancer |
179 | (±¹¿Ü)SCI | Methylation-dependent regulation of HIF-1a stability restricts retinal and tumour angiogenesis |
178 | (±¹¿Ü)SCI | A randomized phase II trial of ERCC1 and RRM1 mRNA expression?based chemotherapy versus docetaxel/carboplatin in advanced non?small cell lung cancer |
177 | (±¹³»)KCI | A case of atypical hemolytic uremic syndrome associated with the c.1273C£¾T mutation in the complement C3 gene |
176 | (±¹¿Ü)SCIE | Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma |
175 | (±¹¿Ü)SCI | Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non?Small-Cell Lung Cancer: KCSG-LU05-04 |
174 | (±¹¿Ü)SCI | Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B-cell lymphoma patients |
Copyright ¨Ï chamc, All rights reserved.